World status of monitoring of iodine deficiency disorders control programs

被引:102
作者
Delange, F
Bürgi, H
Chen, ZP
Dunn, JT
机构
[1] ICCIDD, B-1170 Brussels, Belgium
[2] Univ Brussels, Brussels, Belgium
[3] Int Council Control Iodine Deficiency, Solothurn, Switzerland
[4] Int Council Control Iodine Deficiency Disorders, Tianjin, Peoples R China
[5] Med Univ Tianjin, Tianjin, Peoples R China
[6] Int Council Control Iodine Deficiency Disorders, Charlottesville, VA USA
[7] Univ Virginia Hlth Syst, Charlottesville, VA USA
关键词
D O I
10.1089/105072502761016557
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Monitoring and evaluation are the last phases of a national iodine deficiency disorders (lDD) control program but among the most important. This paper summarizes the latest recommendations by the World Health Organization (WHO), the United Nations Children's Fund (UNICEF), and the International Council for Control of Iodine Deficiency Disorders (ICCIDD) about indicators and their normative values for monitoring the progress of IDD elimination and illustrates the successful monitoring programs in Switzerland and in China. Salt is the usual vehicle for iodine supplementation and quality control for iodine content can be assessed quantitatively by titration and qualitatively by simple test kits that can be used in the field. The most useful indicator of iodine nutrition is the median urinary iodine concentration. Thyroid size, especially by ultrasound, and neonatal thyrotropin (TSH) are also valuable. In Switzerland, access to iodized salt on a voluntary basis started in 1922. The initial level of iodization, 1.9-3.75 ppm iodine as potassium iodide (KI), was slowly increased to 15 ppm, and recently to 20 ppm, after careful epidemiologic and biologic monitoring. Elimination of IDD has been highly successful. The program costs US $0.07 U.S. dollars per year per person. In China, a national program of iodized salt (10-30 ppm) started in 1960 under the authority of the central government and rapidly expanded. National monitoring surveys have taken place every 2 years since 1993. Median urinary iodine, initially low, increased to 165 mug/L in 1995 and to 306 mug/L in 1999, prompting a decrease in the amount of iodine added to salt. The total goiter rate decreased to 20.4% in 1995 and to 8.8% in 1999. IDD can presently be considered as eliminated in China. Review of monitoring in the 128 other major countries affected by IDD shows extremely variable achievements, with evidence of IDD elimination in at least 18 additional countries. Some countries that were severely iodine deficient in the past are now exposed to iodine excess and risk its effects. Sustainable elimination of IDD is within reach and would constitute an unprecedented global success story in the field of noncommunicable diseases, but continuing vigorous action is required to attain this goal.
引用
收藏
页码:915 / 924
页数:10
相关论文
共 65 条
[1]  
[Anonymous], 1852, CR ACAD SCI
[2]  
[Anonymous], 2001, ARSENIC ARSENIC COMP, P1
[3]  
[Anonymous], ICCIDD NEWSL
[4]  
Bayard O, 1923, SCHWEIZ MED WOCHENSC, V53, P732
[5]  
Bayard O., 1923, SCHWEIZ MED WOCHENSC, V53, P703
[6]  
BIRCHER E, 1929, SCHWEIZ MED WOCHENSC, V59, P123
[7]  
Bircher Heinrich, 1883, ENDEMISCHE KROPF SEI
[8]  
BLEICHRODT N, 1994, DAMAGED BRAIN OF IODINE DEFICIENCY, P195
[9]   Iodine-induced thyrotoxicosis in Kivu, Zaire [J].
Bourdoux, PP ;
Ermans, AM ;
Mukalay, AMW ;
Filetti, S ;
Vigneri, R .
LANCET, 1996, 347 (9000) :552-553
[10]   IODINE DEFICIENCY DISEASES IN SWITZERLAND 100 YEARS AFTER KOCHER,THEODOR SURVEY - A HISTORICAL REVIEW WITH SOME NEW GOITER PREVALENCE DATA [J].
BURGI, H ;
SUPERSAXO, Z ;
SELZ, B .
ACTA ENDOCRINOLOGICA, 1990, 123 (06) :577-590